Physician profile
James Zhang
NPI 1467816041
$2,900.89
in general payments reported to CMS, 2019-2025
9 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $160 · 2022: $105 · 2023: $1,327 · 2024: $1,067 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,329 · Food and Beverage: $980 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,329.48 |
| Food and Beverage | $980.32 |
| Education | $325.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,524.75 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Medtronic, INC. | $60.00 | 2025 | Corevalve Evolut R |
| Amgen INC. | $52.22 | 2022-2023 | Repatha |
| Pfizer INC. | $35.00 | 2020 | |
| Inari Medical, INC. | $33.80 | 2022 | |
| Boston Scientific Corporation | $28.63 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $24.73 | 2023 | Arcalyst |
| Teleflex LLC | $16.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.